OxyContin OP 80mg โ The Complete Medical Guide
Introduction to OxyContin OP 80mg
OxyContin OP 80mg is anย abuse-deterrent, extended-release oxycodone formulationย classified as aย Schedule II controlled substance. This maximum-strength tablet is reserved forย management of severe, around-the-clock pain in opioid-tolerant patients. The “OP” designation indicates it containsย physical and chemical barriersย to deter crushing, snorting, or injecting – though risks of misuse and addiction remain significant.
Percocet 10-325mg
Percocet 10-325mg is a combination prescription medication used to manage moderate to severe pain. It contains 10 mg of oxycodone, a powerful opioid, and 325mg of acetaminophen, a pain reliever that enhances the effects of oxycodone. This formulation provides effective pain relief for conditions such as post-surgical pain, injury, or chronic pain. Due to its opioid content, Percocet 10-325 mg should be used strictly as prescribed to avoid the risks of misuse, addiction, and overdose. Always follow your healthcare providerโs instructions for safe and effective pain management.
Medical Uses & Indications
FDA-Approved Uses
โ
ย Severe chronic painย requiring continuous opioid therapy
โ
ย Cancer pain managementย in highly opioid-tolerant patients
โ
ย Pain uncontrolled by lower-dose opioids
Key Clinical Features
โขย Formulation:ย Abuse-deterrent extended-release
โขย Onset:ย 1-2 hours
โขย Duration:ย 12-hour controlled release
โขย Equianalgesic ratio:ย 80mg q12h โ 120mg oral morphine daily
โขย DEA Classification:ย Schedule II (Highest abuse potential)
Pharmacology & Mechanism
Neurochemical Action
โข Full ฮผ-opioid receptor agonist
โข ฮบ-opioid receptor partial agonist
โข Sustained activation of pain modulation pathways
Abuse-Deterrent Properties
โขย Hard plastic coatingย resists crushing
โขย Viscous gel formationย when dissolved
โขย Not completely abuse-proofย (oral abuse still possible)
Dosing & Administration
Strict Eligibility Criteria
โขย Confirmed opioid tolerance:ย โฅ160mg oral morphine equivalent daily
โขย Stable pain patternย (Not episodic/breakthrough)
โขย Failed trials of lower-dose opioids
Conversion Protocol
Calculate total daily morphine equivalent
Reduce by 25-50% (incomplete cross-tolerance)
Divide by 2 for q12h dosing
Critical Safety Notes
โ ย Hospital initiation mandatory
โ ย Must swallow wholeย (never cut/crush/chew)
โ ย Requires dual prescriber verification
โ ย Naloxone rescue kit mandatory
Safety Profile
Common Adverse Effects
โข Severe constipation (universal)
โข Nausea/vomiting (50-60%)
โข Profound sedation
โข Cognitive impairment
Black Box Warnings
โย High potential for addiction and abuse
โย Life-threatening respiratory depression
โย Accidental ingestion can be fatal
โย Concomitant CNS depressant danger
Risk Mitigation Strategies
Prescribing Safeguards
Specialist pain management consultationย required
Triplicate prescription formsย in most states
Weekly follow-upsย for first 3 months
Random pill counts and UDS
Patient Safety Measures
โขย Biometric locked storageย required
โขย Mandatory caregiver training
โขย Medication disposal systemย provided
โขย Absolute alcohol prohibition
Clinical Alternatives
For Severe Chronic Pain
โขย Xtampza ER (abuse-deterrent oxycodone)
โขย Methadoneย (For select patients)
โขย Fentanyl transdermal
Non-Opioid Options
โขย Intrathecal pump therapy
โขย Dorsal column stimulation
โขย Adjuvant medications
Special Population Considerations
| Population | Consideration | Action |
|---|---|---|
| Elderly (โฅ65) | CONTRAINDICATED | – |
| Hepatic impairment | CONTRAINDICATED | – |
| Renal (CrCl<30) | CONTRAINDICATED | – |
| Pediatric | CONTRAINDICATED | – |




Reviews
There are no reviews yet.